2-(substituted-phenyl)amino-imidazoline derivatives
AssigneeSyntex (U.S.A.) Inc.
InventorsKeith Roger Bley, Robin Douglas Clark, Alam Jahangir, Bruce Andrew Kowalczyk, Francisco Javier Lopez-Tapia, Alexander Victor Muehldorf, Counde O'Yang, Thomas Weitao Sun
Life of this patent
Estimating the term…
Abstract
This invention relates to IP receptor antagonists selected from the group of compounds represented by Formula I: where: R1 is a group represented by formula (A), (B) or (C); and other substituents as defined in the specification, and their pharmaceutically acceptable salts or crystal forms thereof; and pharmaceutical compositions containing them; and methods for their use as therapeutic agents.
Claims6
A compound of Formula I:
- wherein R3 is selected from the group consisting of alkyl and alkyloxy of from 1 to 8 carbon atoms;
- and
- pharmaceutically acceptable salts thereof.
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and an effective amount of a compound of Formula I:
- wherein R3 is selected from the group consisting of alkyl and alkyloxy of from 1 to 8 carbon atoms;
- and
- pharmaceutically acceptable salts thereof.
Dependencies are inferred from the claim text.